For years, medical treatments for obesity and type 2 diabetes have focused on the brain and gut. Drugs in the glucagon like ...

An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a ...

Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 ...

A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...

A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to ...

The Food and Drug Administration recently approved Belgium-based Janssen Pharmaceuticals’ drug Invokamet XR for first-line use to improve glycemic control in diabetic adults when paired with diet and ...

A new federal negotiation round reshapes how your most expensive diabetes and cancer treatments will be priced under Medicare ...

Some experts cited the case of Slentrol, an older weight loss drug for dogs made by Pfizer’s animal health division (which ...

While type 1 and type 2 diabetes typically occupy distinct places in healthcare, research is showing an increase of patients ...

For patients with diabetes, the days after hospital discharge can be as risky as the days leading up to admission. Clinicians ...